Intranasal CNS Delivery - Bryant McGill

# Intranasal CNS Delivery **Aliases:** Subsense intranasal delivery **Entity class:** Organization or institution **Collection:** [[collections/Neurotech|Neurotech]] ## Definition **Intranasal CNS Delivery** is an organization or institution. Intranasal CNS Delivery is associated with [[wiki/Size-Dependent Intranasal Administration of Magnetoelectric Nanoparticles|Size-Dependent Intranasal Administration of Magnetoelectric Nanoparticles]]. The entry centers on the organization's documented work, partners, users, and institutional lineage, so its own role remains distinct from the roles of adjacent programs and technologies. ## Relationships  This entry is routed through [[collections/Neurotech|Neurotech]]. Its source context is developed in [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]], [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]], [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]], and [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]]. Status-qualified source edges are preserved in the terminal Research Edges section. ### Additional Documented Relationships - **Intranasal CNS Delivery** is associated with [[wiki/Size-Dependent Intranasal Administration of Magnetoelectric Nanoparticles|Size-Dependent Intranasal Administration of Magnetoelectric Nanoparticles]].  ## Research Edges  #### Master relationship graph patch — 2026-09-10 **Resolved aliases:** `Subsense intranasal delivery` **Collection:** [[collections/Neurotech|Neurotech]] **Relationship source:** [[research/Neurotechnology Ecosystem Relationship Graph - 2026-09-10|Neurotechnology Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 90 — `technically_overlaps` → [[wiki/Size-Dependent Intranasal Administration of Magnetoelectric Nanoparticles|2021 MENP intranasal BBB/localization study]]** — **STRONG_TECHNICAL_LINEAGE**; evidence `SUB_HOME`, `MENP_INTRNASAL`. High-value research genealogy; corporate connection not established by public sources reviewed.  ## Research Inference Attractors  These are secondary semantic placements for the inference attractor network. Each statement keeps its original ID and tier; its canonical cluster page links back to every destination. Source register: [[research/Research Inferences|Research Inferences]]. Interpretive context: [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0311 — Established.** Genetic circuits implementing sensing, logic, and actuation inside living cells are a mature engineering discipline with design tools and part registries. Computation is already being deployed in cells, which makes in-body information processing an existing capability rather than a projection. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]] - **INF-0315 — Strongly indicated.** Lipid nanoparticles with tissue-selective formulations route payloads to organs by chemistry rather than by catheter. Addressing by formulation is a logical addressing scheme for the body, and each new tropism added to the library is a new deliverable destination. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]] - **INF-0316 — Plausible.** Payloads released by ultrasound, magnetic field, or light give an external operator temporal control over an internal event. Separating delivery from activation means a therapeutic can be positioned in advance and fired on a schedule the clinician chooses. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]] - **INF-0317 — Plausible.** An implanted reservoir with a sensor and a controller delivers a drug in response to a measured state rather than a clock. Continuous titration against a biomarker collapses the difference between diagnosis and treatment into one running process. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]] - **INF-0334 — Strongly indicated.** LNP delivery is non-viral and redosable, avoiding the anti-capsid immunity that limits AAV to a single administration. Redosability converts gene editing from a one-shot event into a repeatable clinical procedure, which is the property continuous genetic maintenance requires. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0348 — Unresolved.** Somatic editing is broadly permitted while heritable editing is broadly prohibited, and the boundary depends on delivery specificity that improves continuously. Resolution will come through a jurisdictional divergence rather than an international agreement. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]]